Job opportunities

Calixar and Synthelis team up to provide unique membrane protein services

Post on 31 January 2013

Calixar

Calixar (Lyon), a company specialized in the isolation and crystallization of native and functional membrane proteins, and Synthelis (Grenoble), which is specialized in the production and vectorization of these same molecules, team-up within The Membrane Protein Alliance for the production and isolation of all types of membrane protein targets for drug discovery (including GPCR, ion channels, transporters, enzymes and viral targets). The results of this collaboration will have applications ranging from the development of antibodies to the discovery of new drugs, including the determination of the targets structure and vaccine formulations.

 

 

Synthelis

Membrane Alliance

This unique partnership will enable life sciences researchers and industry to access a comprehensive and innovative range of services to obtain currently unavailable therapeutic targets.

Instead of trying to produce these proteins themselves, users will be given access to state-of-the-art production and purification technologies, enabling them to concentrate on their core activities. Furthermore, thanks to the critical mass of skills and patented technologies made available to them, they will be assured of obtaining targets in their native conformation, thus guaranteeing the success of their programs for developing new drugs, vaccines and therapeutic antibodies.

 

Membrane Protein Alliance

 

For further information, go to: 

http://www.membraneproteinalliance.com.

 

Events

 

Come visit us at Bio-Partnering America (Vancouver), Bio-US (Chicago) and PEGS (Boston) 2013.

 

Contact

 

Anass JAWHARI, PhD
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.